“If you’re starting a biotechnology company and thinking of developing anything other than a super-high-priced medicine for a niche market, this morning’s news that Questcor Pharmaceuticals is being bought by Dublin-based specialty pharma Mallinckrodt for $5.6 billion may make you reconsider. Forget new drugs for any common diseases, find an [...]
Best Of FORBES: WWE Stock Drops, 2014's Biggest Dividend Increases
#BiotechnologyCompany, #QuestcorPharmaceuticals, #NicheMarket
Nessun commento:
Posta un commento